Allergan Targets Sandoz Over Generic Latisse

By Allison Grande · April 18, 2011, 5:28 PM EDT

Allergan Inc. launched a patent infringement suit Friday in a North Carolina federal court over Sandoz Inc.'s efforts to manufacture a generic version of Latisse, a treatment to stimulate eyelash growth....

To view the full article, register now.

Documents

Case Information

Case Title

ALLERGAN, INC., et al v. SANDOZ, INC.

Case Number

1:11-cv-00298

Court

North Carolina Middle

Nature of Suit

Patent

Date Filed

April 15, 2011